AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca PLC

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Inventories

Inventories %Chg

Inventories Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Goodwill

Goodwill %Chg

Goodwill Common Size

Long-Term Investments

Long-Term Investments %Chg

Long-Term Investments Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Short-Term Debt

Short-Term Debt %Chg

Short-Term Debt Common Size

Current Portion of Leases

Current Portion of Leases %Chg

Current Portion of Leases Common Size

Other Current Liabilities

Other Current Liabilities %Chg

Other Current Liabilities Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Long-Term Debt

Long-Term Debt %Chg

Long-Term Debt Common Size

Leases

Leases %Chg

Leases Common Size

Other Long-Term Liabilities

Other Long-Term Liabilities %Chg

Other Long-Term Liabilities Common Size

Total Long-Term Liabilities

Total Long-Term Liabilities %Chg

Total Long-Term Liabilities Common Size

Total Liabilities

Total Liabilities %Chg

Total Liabilities Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Additional Paid-in Capital

Additional Paid-in Capital %Chg

Additional Paid-in Capital Common Size

Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income %Chg

Accumulated Other Comprehensive Income Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Total Common Shareholders' Equity

Total Common Shareholders' Equity %Chg

Total Common Shareholders' Equity Common Size

Minority Interests and Other

Minority Interests and Other %Chg

Minority Interests and Other Common Size

Total Shareholders' Equity

Total Shareholders' Equity %Chg

Total Shareholders' Equity Common Size

Total Liabilities and Shareholders' Equity

Total Liabilities and Shareholders' Equity %Chg

Total Liabilities and Shareholders' Equity Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Cash and Cash Equivalents	8,143	5,488	5,840	6,166	6,329	7,832	5,369	4,831	3,324	5,018	6,240
Short-Term Investments	39	166	122	239	69	160	849	849	1,230	884	613
Total Cash and Cash Equivalents	8,182	5,654	5,962	6,405	6,398	7,992	6,218	5,680	4,554	5,902	6,853
Accounts Receivable	14,338	12,972	12,126	10,521	9,644	7,022	5,761	5,574	5,009	4,573	6,622
Total Trade Receivables	14,338	12,972	12,126	10,521	9,644	7,022	5,761	5,574	5,009	4,573	6,622
Inventories	6,593	5,288	5,424	4,699	8,983	4,024	3,193	2,890	3,035	2,334	2,143
Other Current Assets	827	1,913	1,542	968	1,219	506	391	1,447	552	453	389
Total Current Assets	29,940	25,827	25,054	22,593	26,244	19,544	15,563	15,591	13,150	13,262	16,007
Net Property, Plant & Equipment	13,783	11,647	10,502	9,449	10,171	8,917	8,335	7,421	7,615	6,848	6,413
Net Intangible Assets	38,191	37,177	38,089	39,307	42,387	20,947	20,833	21,959	26,188	27,586	22,646
Goodwill	21,219	21,025	20,048	19,820	19,997	11,845	11,668	11,707	11,825	11,658	11,800
Long-Term Investments	2,286	1,900	1,677	1,142	1,237	1,147	1,459	922	1,036	826	543
Other Long-Term Assets	9,037	6,459	5,749	4,172	5,327	4,329	3,519	3,051	3,540	2,346	2,647
Total Assets	114,456	104,035	101,119	96,483	105,363	66,729	61,377	60,651	63,354	62,526	60,056

Liabilities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Accounts Payable	25,028	22,465	22,374	19,040	18,938	15,785	13,987	12,841	11,641	10,486	11,663
Short-Term Debt	6,174	2,337	5,129	5,314	1,660	2,194	1,822	1,754	2,247	2,307	916
Current Portion of Leases	379	339	271	228	233	192	188	—	—	—	—
Other Current Liabilities	2,473	2,725	2,768	1,711	1,763	2,136	2,120	1,697	2,495	2,463	2,290
Total Current Liabilities	34,054	27,866	30,542	26,293	22,594	20,307	18,117	16,292	16,383	15,256	14,869
Long-Term Debt	24,700	26,506	22,365	22,965	28,134	17,505	15,730	17,359	15,560	14,501	14,137
Leases	1,379	1,113	857	725	754	489	487	—	—	—	—
Other Long-Term Liabilities	8,352	7,679	8,189	9,442	14,594	12,790	12,447	12,956	14,769	16,100	12,541
Total Long-Term Liabilities	34,431	35,298	31,411	33,132	43,482	30,784	28,664	30,315	30,329	30,601	26,678
Total Liabilities	68,485	63,164	61,953	59,425	66,076	51,091	46,781	46,607	46,712	45,857	41,547

Equity	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Common Stock	388	388	388	387	387	328	328	317	317	316	316
Additional Paid-in Capital	35,243	35,226	35,789	35,756	35,727	8,572	8,542	5,028	4,994	4,952	4,905
Accumulated Other Comprehensive Income	2,044	2,012	1,464	1,468	1,444	1,423	1,445	1,440	1,428	1,446	1,435
Retained Earnings	8,213	3,160	1,502	-574	1,710	5,299	2,812	5,683	8,221	8,140	11,834
Total Common Shareholders' Equity	45,888	40,786	39,143	37,037	39,268	15,622	13,127	12,468	14,960	14,854	18,490
Minority Interests and Other	83	85	23	21	19	16	1,469	1,576	1,682	1,815	19
Total Shareholders' Equity	45,971	40,871	39,166	37,058	39,287	15,638	14,596	14,044	16,642	16,669	18,509
Total Liabilities and Shareholders' Equity	114,456	104,035	101,119	96,483	105,363	66,729	61,377	60,651	63,354	62,526	60,056